Tetragenococcus halophilus (Mees) Collins et al. 拉丁名
(ATCC? 21786?) 統(tǒng)一編號(hào)
Deposited As Pediococcus halophilus Mees Strain Designations [FERM-P 1414]
Application 應(yīng)用 Produces protein hydrolysates
Biosafety Level 生物安全等級 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 freeze-dried
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol? no
Type Strain 模式菌株 no
Medium 培養(yǎng)基 ATCC? Medium 977: Sodium acetate medium I
Growth Conditions 生長條件
Temperature 培養(yǎng)溫度: 30.0°C
Name of Depositor Kikkoman Shioyu Co., Ltd. U.S. Patent Number 3,932,671
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
References 參考文獻(xiàn) Yokotsuka T, et al. Process for producing protein hydrolyzate. US Patent 3,932,671 dated Jan 13 1976